Less Ads, More Data, More Tools Register for FREE

Pin to quick picks65WK.L Regulatory News (65WK)

  • There is currently no data for 65WK

Intention To Exercise Regulatory Call

24 Dec 2021 08:47

RNS Number : 7558W
Santander UK Plc
24 December 2021
 

THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT (A) QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE MARKET ABUSE REGULATION (EU) 596/2014 ("EU MAR"); AND (B) QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE MARKET ABUSE REGULATION (EU) 596/2014, AS IT FORMS PART OF DOMESTIC LAW OF THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (AS AMENDED) ("UK MAR")

SANTANDER UK PLC 2 Triton SquareRegent's Place London, NW1 3ANRegistered in England and Wales with company number 02294747 (the "Issuer")

INTENTION TO EXERCISE REGULATORY CALL£300,000,000 7.037 per cent. Step-up Callable Perpetual Reserve Capital Instruments (ISIN: XS0124569566) (the "RCIs")

In accordance with Articles 77 and 78 of Regulation (EU) No 575/2013 on prudential requirements for credit institutions and investment firms of the European Parliament and of the Council of 26 June 2013 as it forms part of domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018 (as amended) (the "CRR"), the Issuer has obtained the permission of the Prudential Regulation Authority to exercise the regulatory call option (the "Regulatory Call") under Condition 7(d) (Exchange, Variation or Redemption for Regulatory Purposes) of the Terms and Conditions of the RCIs.

Pursuant to Articles 484 and 486 of the CRR, the CRR grandfathering period will end on 31 December 2021 (the "Grandfathering Deadline") with the effect that the RCIs will no longer be recognised as additional tier 1 capital. Further, the Issuer will be unable to exchange the RCIs for, or vary the RCIs into, "Upper Tier 2 Securities" which qualify as "Upper Tier 2 Capital" following the Grandfathering Deadline in accordance with Condition 7(d) (Exchange, Variation or Redemption for Regulatory Purposes), as such tier of capital (a) no longer exists under the CRR, and (b) has no equivalent under the CRR. As such, the Issuer intends to exercise the Regulatory Call and redeem all of the outstanding RCIs in accordance with their Terms and Conditions, at their principal amount (together with any Outstanding Payments) on 14 February 2022, which is the next Coupon Payment Date.

Please note that this announcement does not constitute a formal notice of redemption for the purposes of Condition 7(d) (Exchange, Variation or Redemption for Regulatory Purposes) of the Terms and Conditions of the RCIs. The Issuer intends to give formal notice of the proposed redemption to the RCI Holders in due course following the end of the CRR grandfathering period, and following the satisfaction of all applicable conditions to the exercise of the Regulatory Call, as set out in Condition 7(d) (Exchange, Variation or Redemption for Regulatory Purposes).

Capitalised terms used, but not defined, in this notice shall have the meanings given to them in the Terms and Conditions of the RCIs.

Santander UK plc 24 December 2021

For further information, please contact:

Medium Term FundingSantander UK plc2 Triton SquareRegent's PlaceLondon NW1 3AN

Email: MTF@santander.co.uk

 

This announcement is released by the Issuer and contains information that qualified or may have qualified as inside information for the purposes of Article 7 of EU MAR and UK MAR, encompassing information relating to the Regulatory Call described above. For the purposes of (a) EU MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055; and (b) UK MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, as it form part of domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018 (as amended), this announcement is made by Tom Ranger, Treasurer at Santander UK plc.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFEDSALEFSELE
12
Date   Source Headline
28th Apr 20217:00 amRNSQuarterly Management Statement - Q1 2021
16th Apr 20218:58 amRNSPART VII BANKING BUSINESS TRANSFER SCHEME
22nd Mar 20213:27 pmRNSSeries of Notes Pricing of Cash Tender Offers
22nd Mar 202112:49 pmRNSSeries Notes - Increase to Tender & Early Results
18th Mar 20215:30 pmRNSAGM Statement
8th Mar 20212:58 pmRNSTender Offer - Two series of Notes
3rd Mar 20211:21 pmRNSPublication of Supplementary Prospectus
2nd Mar 20216:22 pmRNSAnnual Financial Report
3rd Feb 20212:09 pmRNSPublication of Supplementary Prospectus
3rd Feb 20217:15 amRNSQ4 2020 - Quarterly Management Statement
18th Dec 20204:22 pmRNSDirectorate Change
18th Dec 20203:38 pmRNSNotice of Pricing Terms to Holders of Bonds
18th Dec 202011:41 amRNSNotice of Meeting Results - Holders of Bonds
15th Dec 20201:00 pmRNSExpiration and Results of Cash Tender Offers
1st Dec 20205:09 pmRNSPricing of Tender Offers for Four Series of Notes
1st Dec 20201:28 pmRNSEarly Results Tender Offers for Four Series Notes
26th Nov 202012:26 pmRNSNotice to Covered Bondholders
12th Nov 20204:58 pmRNSCash Tender Offers for Four Series of Notes
27th Oct 20205:45 pmRNSPublication of Supplementary Prospectus
27th Oct 20201:23 pmRNSPublication of Supplementary Prospectus
27th Oct 20207:15 amRNSQ3 2020 - Quarterly Management Statement
7th Sep 20201:59 pmRNSNotice of Early Redemption for Noteholders
14th Aug 20203:49 pmRNSNotice of Early Redemption - Fixed Rate Notes
11th Aug 20203:08 pmRNSPublication of Supplementary Prospectus
11th Aug 20202:59 pmRNSPublication of Supplementary Prospectus
11th Aug 20207:15 amRNSHalf-year Report
7th Aug 20207:00 amRNSBoard Changes at Santander UK
4th Aug 20204:59 pmRNSArticle 17
3rd Aug 20208:32 amRNS1172 ISE Delisting Announcement
29th Jul 202012:34 pmRNSPublication of Supplementary Prospectus
29th Jul 202012:09 pmRNSPublication of Supplementary Prospectus
29th Jul 20207:15 amRNSQuarterly Management Statement - 30 June 2020
21st Jul 20208:31 amRNSPOP Delisting
9th Jul 20203:42 pmRNSArticle 8
6th Jul 20207:37 amRNS1170 ISE Delisting Announcement
30th Jun 20205:03 pmRNSPublication of a Prospectus
16th Jun 20206:44 pmRNSPublication of a Prospectus
12th May 20208:20 amRNSNOTICE OF DELISTING
11th May 20203:26 pmRNSArticle 8
30th Apr 20202:02 pmRNSPublication of Supplementary Prospectus
30th Apr 20208:25 amRNSNotice of Delisting
28th Apr 20207:15 amRNS1st Quarter Results
16th Apr 202012:11 pmRNSGlobal Covered Bond Programme - Final Terms Amend
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.